EPIRUS BIOPHARMACEUTICALS IN's ticker is EPRSQ and the CUSIP is 29428P107. A total of 24 filers reported holding EPIRUS BIOPHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $44,000 | -95.6% | 2,223,922 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $1,005,000 | -83.2% | 2,223,922 | 0.0% | 0.01% | -81.4% |
| Q1 2016 | $5,982,000 | -13.0% | 2,223,922 | 0.0% | 0.06% | +18.0% |
| Q4 2015 | $6,872,000 | -30.1% | 2,223,922 | 0.0% | 0.05% | +4.2% |
| Q3 2015 | $9,830,000 | -22.6% | 2,223,922 | 0.0% | 0.05% | -18.6% |
| Q2 2015 | $12,699,000 | -36.2% | 2,223,922 | 0.0% | 0.06% | -41.6% |
| Q1 2015 | $19,904,000 | +57.8% | 2,223,922 | 0.0% | 0.10% | +31.2% |
| Q4 2014 | $12,610,000 | -21.1% | 2,223,922 | 0.0% | 0.08% | -28.0% |
| Q3 2014 | $15,990,000 | – | 2,223,922 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|